• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

    29.55 -6.19 (-17.31%)
    Streaming Delayed Price Updated: 2:31 PM EDT, Aug 6, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Collegium Pharmaceutical, Inc. - Common Stock

    < Previous 1 2 3 4 Next >
    News headline image
    Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston
    New headquarters reflects Collegium's long-term vision and commitment to Massachusetts 
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium to Participate in 2026 Jefferies Global Healthcare Conference
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium to Report First Quarter 2026 Financial Results on May 7, 2026
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium to Present New Real-World Data at PainConnect 2026
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium to Participate in Upcoming Investor Conferences
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Boston Legacy FC Announces Sensory Room Sponsorship with Collegium Pharmaceutical
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium to Report Fourth Quarter and Full-Year 2025 Financial Results on February 26, 2026
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium Provides 2026 Financial Guidance and Business Update
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium Announces the Closing of $980 Million Syndicated Credit Facility
    Five-Year Financing with Favorable Terms that Significantly Reduce Interest Rate 
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium to Participate in Upcoming Investor Conferences
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Paris Hilton Collaborates with Collegium Pharmaceutical to Share Her Personal ADHD Journey and Experience with Treatment
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing
    – Collegium to Ring Nasdaq Opening Bell on October 14, 2025 – 
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium to Participate in Upcoming Investor Conferences
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium Reports Second Quarter 2025 Financial Results; Raises 2025 Outlook
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium Announces $150 Million Share Repurchase Program
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Abuse Deterrent Formulations Market Exploding While Estimated to Reach $39 Million In 2025 and $54 Million By 2030
    EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:NTRBW),(NYSE:PFE),(NASDAQ:COLL),(NYSE:TEVA),(NYSE:EBS) EQNX::TICKER_END 
    Via FinancialNewsMedia
    Topics Death
    < Previous 1 2 3 4 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.